Effect of neoadjuvant chemoradiotherapy on p53 and SOX2 protein expression in esophageal adenocarcinoma.

Suzuki, Lucia; Nieboer, Daan; van Lanschot, Jan Jb; Spaander, Manon Cw; Looijenga, Leendert Hj; Biermann, Katharina

Suzuki, Lucia; Nieboer, Daan; van Lanschot, Jan Jb; Spaander, Manon Cw; Looijenga, Leendert Hj; Biermann, Katharina.

Affiliation

Suzuki L; Department of Pathology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
Nieboer D; Department of Public Health, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
van Lanschot JJ; Department of Surgery, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
Spaander MC; Department of Gastroenterology & Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
Looijenga LH; Department of Pathology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
Biermann K; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Biomark Med ; 14(9): 785-793, 2020 06.

Article de En | MEDLINE | ID: mdl-32677456

Sujet(s)
Mots clés

biomarkers; esophageal adenocarcinoma; esophageal neoplasms; neoadjuvant therapy SOX2 protein; tumor suppressor protein p53

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'oesophage / Adénocarcinome / Régulation de l'expression des gènes tumoraux / Protéine p53 suppresseur de tumeur / Facteurs de transcription SOX-B1 / Chimioradiothérapie Type d'étude: Diagnostic_studies / Prognostic_studies Limites: Aged / Female / Humans / Middle aged Langue: En Journal: Biomark Med Sujet du journal: BIOQUIMICA / MEDICINA Année: 2020 Type de document: Article Pays d'affiliation: Pays-Bas Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google